Advanced

Fallbeskrivning. Rosiglitazonbehandling gav kraftfull effekt, men fick ändå avbrytas

Ridderstråle, Martin LU and Groop, Leif LU (2002) In Läkartidningen 99(5). p.407-410
Abstract
The thiazolidinediones were introduced as oral hypoglycemic drugs in Sweden during the fall of 2000. A case is reported in which a woman with insulin-dependent type-2 diabetes and both macro- and microangiopathy and pronounced insulin resistance was treated with rosiglitazone (Avandia). Within three months insulin doses could be reduced by 36% (from 176 to 112 units insulin daily) and concomitantly Ery-HbA1c was reduced from 8.4 to 5.3%. In spite of this dramatic effect on glucose homeostasis administration of the drug had to be discontinued due to critical congestive heart failure.
Please use this url to cite or link to this publication:
author
organization
alternative title
A case report. Rosiglitazone treatment was highly effective yet had to be terminated
publishing date
type
Contribution to journal
publication status
published
subject
in
Läkartidningen
volume
99
issue
5
pages
407 - 410
publisher
Swedish Medical Association
external identifiers
  • pmid:11881246
  • scopus:0037204317
ISSN
0023-7205
language
Swedish
LU publication?
yes
id
8049f080-38d8-468b-8db8-66703e6fec5e (old id 1124940)
alternative location
http://ltarkiv.lakartidningen.se/artNo24143
date added to LUP
2008-05-29 15:15:43
date last changed
2017-01-01 07:21:09
@article{8049f080-38d8-468b-8db8-66703e6fec5e,
  abstract     = {The thiazolidinediones were introduced as oral hypoglycemic drugs in Sweden during the fall of 2000. A case is reported in which a woman with insulin-dependent type-2 diabetes and both macro- and microangiopathy and pronounced insulin resistance was treated with rosiglitazone (Avandia). Within three months insulin doses could be reduced by 36% (from 176 to 112 units insulin daily) and concomitantly Ery-HbA1c was reduced from 8.4 to 5.3%. In spite of this dramatic effect on glucose homeostasis administration of the drug had to be discontinued due to critical congestive heart failure.},
  author       = {Ridderstråle, Martin and Groop, Leif},
  issn         = {0023-7205},
  language     = {swe},
  number       = {5},
  pages        = {407--410},
  publisher    = {Swedish Medical Association},
  series       = {Läkartidningen},
  title        = {Fallbeskrivning. Rosiglitazonbehandling gav kraftfull effekt, men fick ändå avbrytas},
  volume       = {99},
  year         = {2002},
}